HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Vanguard Group Inc.

Vanguard Group Inc. raised its position in shares of HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 1.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 19,113,498 shares of the company’s stock after buying an additional 181,855 shares during the quarter. Vanguard Group Inc. owned 6.47% of HCA Healthcare worth $4,790,225,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the company. Ellevest Inc. lifted its stake in HCA Healthcare by 33.6% during the first quarter. Ellevest Inc. now owns 187 shares of the company’s stock valued at $47,000 after buying an additional 47 shares in the last quarter. Veriti Management LLC lifted its stake in HCA Healthcare by 4.0% during the first quarter. Veriti Management LLC now owns 1,297 shares of the company’s stock valued at $325,000 after buying an additional 50 shares in the last quarter. Oliver Luxxe Assets LLC increased its holdings in shares of HCA Healthcare by 0.4% in the 4th quarter. Oliver Luxxe Assets LLC now owns 13,470 shares of the company’s stock valued at $3,461,000 after purchasing an additional 51 shares during the period. Highland Private Wealth Management increased its holdings in shares of HCA Healthcare by 6.4% in the 1st quarter. Highland Private Wealth Management now owns 876 shares of the company’s stock valued at $220,000 after purchasing an additional 53 shares during the period. Finally, Balasa Dinverno & Foltz LLC increased its holdings in shares of HCA Healthcare by 4.5% in the 1st quarter. Balasa Dinverno & Foltz LLC now owns 1,244 shares of the company’s stock valued at $312,000 after purchasing an additional 54 shares during the period. 65.75% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of HCA stock opened at $216.21 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.55 and a debt-to-equity ratio of 87.46. HCA Healthcare, Inc. has a 12 month low of $164.47 and a 12 month high of $279.02. The firm has a market cap of $62.06 billion, a price-to-earnings ratio of 10.40, a PEG ratio of 1.48 and a beta of 1.72. The stock has a 50-day moving average price of $198.32 and a 200 day moving average price of $218.04.

HCA Healthcare (NYSE:HCAGet Rating) last issued its earnings results on Friday, July 22nd. The company reported $4.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.67 by $0.54. HCA Healthcare had a return on equity of 833.68% and a net margin of 10.83%. The firm had revenue of $14.82 billion for the quarter, compared to analysts’ expectations of $14.73 billion. During the same quarter last year, the business earned $4.37 earnings per share. The company’s revenue was up 2.7% compared to the same quarter last year. Research analysts expect that HCA Healthcare, Inc. will post 17.1 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 30th. Shareholders of record on Friday, September 16th will be paid a $0.56 dividend. This represents a $2.24 annualized dividend and a yield of 1.04%. The ex-dividend date is Thursday, September 15th. HCA Healthcare’s payout ratio is 10.77%.

Insiders Place Their Bets

In other HCA Healthcare news, major shareholder Patricia F. Elcan bought 325 shares of the firm’s stock in a transaction that occurred on Monday, July 25th. The shares were acquired at an average cost of $198.66 per share, with a total value of $64,564.50. Following the acquisition, the insider now owns 89,337 shares of the company’s stock, valued at $17,747,688.42. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.50% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on HCA. Bank of America upped their target price on HCA Healthcare from $192.00 to $230.00 in a report on Sunday, July 24th. Loop Capital initiated coverage on HCA Healthcare in a report on Thursday, June 16th. They issued a “buy” rating and a $240.00 price objective on the stock. BMO Capital Markets downgraded HCA Healthcare from a “market perform” rating to an “underperform” rating and lowered their price target for the company from $233.00 to $160.00 in a report on Wednesday, July 6th. Citigroup lowered their price target on HCA Healthcare from $254.00 to $240.00 in a report on Tuesday, July 26th. Finally, The Goldman Sachs Group reduced their price objective on HCA Healthcare from $270.00 to $233.00 and set a “buy” rating for the company in a research report on Tuesday, July 12th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $237.71.

HCA Healthcare Profile

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.